{"id":"W4411970888","doi":"10.1038/s41531-025-01014-y","title":"Beta-adrenoceptor drugs and progression to Parkinson’s disease milestones in a large pooled incident cohort","year":2025,"lang":"en","type":"article","venue":"npj Parkinson s Disease","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"NIHR Newcastle Biomedical Research Centre; Haukeland Universitetssjukehus; Parkinsonfonden; Umeå Universitet; Hjärnfonden; Knut och Alice Wallenbergs Stiftelse; Västerbotten Läns Landsting; UK Research and Innovation; University of Aberdeen; Cambridge University Hospitals; Research Councils UK; Norges Forskningsråd; NIHR Cambridge Biomedical Research Centre; Academy of Medical Sciences; Bupa Foundation; Medical Research Council; Department of Health and Social Care; National Institute for Health and Care Research; Weston Brain Institute; Intercept Pharmaceuticals; Wellcome Trust; Scottish Government; Parkinson's UK; Kempe Foundation; Parkinson Research Foundation","keywords":"Medicine; Dementia; Hazard ratio; Parkinson's disease; Confounding; Internal medicine; Agonist; BETA (programming language); Cohort; Disease; Oncology; Receptor; Confidence interval","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002580181,0.0005518571,0.001238452,0.00103252,0.0004546571,0.001171473,0.0005304309,0.0006277472,0.00112043],"category_scores_gemma":[0.003358503,0.0006308967,0.002076355,0.001318786,0.0002063176,0.0003515971,0.0006248698,0.0006573516,0.0002925581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003745631,"about_ca_system_score_gemma":0.0004846361,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01228119,"about_ca_topic_score_gemma":0.01160728,"domain_scores_codex":[0.9989497,0.000335963,0.0001437498,0.0003419647,0.0001255261,0.0001031582],"domain_scores_gemma":[0.9977739,0.0003810553,0.0006198973,0.0007394516,0.0002698541,0.0002157503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003108181,0.0000486726,0.987416,0.0001224402,0.005614519,0.0001314813,0.00008209598,0.0001669675,0.0006074604,0.00003631322,0.0005124822,0.002153456],"study_design_scores_gemma":[0.0001652857,0.0003875106,0.9941435,0.00003003784,0.003739864,0.0002560632,0.00009833524,0.0003810943,0.000126132,0.00004872127,0.0006105631,0.00001285766],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992067,0.003378395,0.0006983174,0.00003742816,0.00004463266,0.00003877719,0.003080298,0.00003006514,0.0006251259],"genre_scores_gemma":[0.9952129,0.0007987285,0.0003479026,0.00004208265,0.00004705959,0.00005159296,0.003036274,0.00001176596,0.0004516877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01228119,"threshold_uncertainty_score":0.02441937,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01027357715919752,"score_gpt":0.2969264474640812,"score_spread":0.2866528703048837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}